| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Medical technology | |
| #5 | Basic materials chemistry | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Preservation of human bodies | |
| #6 | Unspecified technologies | |
| #7 | Electrotherapy | |
| #8 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zagon Ian S | 13 |
| #2 | Mclaughlin Patricia J | 13 |
| #3 | Sassani Joseph W | 7 |
| #4 | Verderame Michael F | 4 |
| #5 | Smith Jill P | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2013016480A1 | Methods and compositions for treatment of epithelial wounds | |
| EP2424535A2 | Methods and compositions for treating dry eye | |
| US2008146512A1 | Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment | |
| US7122651B1 | Nucleic acid molecules encoding opioid growth factor receptors | |
| US5266574A | Growth regulation and related applications of opioid antagonists |